Both post COVID-19 groups had significantly higher dp TNFα+ IL-2+ SARS-CoV-2 S N-term reactive CD4+ T cells compared to HC (Ab−: p = 0.04; Ab+ p = 0.05). The gene discussed is CD4; the disease is COVID-19.